Xvivo Perfusion AB (publ) (XVIPY) Financials

Stock symbol XVIPY is outdated, potentially delisted? Maybe it is available on other exchange?

XVIPY Assets vs Liabilities

Date	Assets	Liabilities
Dec. 31, 2025	257.9 million	28.3 million
Sept. 30, 2025	251.7 million	30.0 million
June 30, 2025	252.5 million	31.3 million
March 31, 2025	228.9 million	20.2 million

XVIPY Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Dec. 31, 2025	?	?
Sept. 30, 2025	?	?
June 30, 2025	-2.9 million	?
March 31, 2025	-3.3 million	?

XVIPY Net Income

Graph available only for paid members. Upgrade to see it.

Date	Net Income
Dec. 31, 2025	3.4 million
Sept. 30, 2025	454011
June 30, 2025	166393
March 31, 2025	-1.2 million

XVIPY Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Dec. 31, 2025	31.7 million	12.3 million	-
Sept. 30, 2025	29.6 million	-	12.1 million
June 30, 2025	34.2 million	-	11.7 million
March 31, 2025	31.5 million	-	2.9 million

XVIPY Shares Outstanding

No data available :(

XVIPY Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Dec. 31, 2025	8.9 million	2.7 million	8.9 million	-
Sept. 30, 2025	2.1 million	2.5 million	8.8 million	-
June 30, 2025	3.8 million	3.4 million	10.0 million	8.0 million
March 31, 2025	1.8 million	3.5 million	9.6 million	7.4 million

XVIPY Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Dec. 31, 2025	24.1 million	8.5 million
Sept. 30, 2025	19.8 million	6.6 million
June 30, 2025	18.9 million	4.8 million
March 31, 2025	21.8 million	5.8 million

XVIPY

Price: $6.54

52 week price:

4.25

8.74

Exchange: PNK

Sector: Healthcare

Market Capitalization: 824.0 million

Links:

XVIPY on Yahoo Finance